Oscar Health’s Says 2026 Profit Turnaround Gains Steam
Oscar Health is betting on a 2026 profitability turnaround after a challenging Q4 2025, highlighting AI efficiency, h...
Healthcare Stocks
This tag page curates 5 Healthcare Stocks articles to help you assess risks, dividend potential, and notable moves from Chemed to UnitedHealth, helping smarter investment decisions.
57 articles
Ardent Health (ARDT) 2025 Q4 Earnings Outlook for Investors
As Ardent Health closes 2025, the Q4 results shed light on margins, volumes, and balance-sheet health. This analysis ...
Viemed (VMD) 2025 Earnings Outlook for Investors Today
Viemed's 2025 earnings outlook hinges on growing demand for home respiratory care, reimbursement dynamics, and cost c...
Hims Hers: Telehealth Growth and Investor Tactics for Beginners
Telehealth is changing how we get care—and how we invest. This article breaks down the growth story, uses Hims & Hers...
Orthofix (OFIX) 2025 Earnings Outlook and Key Drivers
As orthofix prepares its 2025 earnings narrative, investors weigh product mix shifts, margins, and macro headwinds. T...
Option Care (OPCH) Earnings: A Deep-Dive for Investors
Option Care earnings season sheds light on the shifting landscape of home infusion and specialty care. This guide bre...
Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Celcuity Stock Soars 700% After Major Investor Buy
A dramatic run in Celcuity shares drew attention from traders and long-term investors alike. This article explains th...
Reason Medtronic Stock Never: One Key Reason to Buy
If you’re hunting for a lifelong holding, the dividend track record of Medtronic is hard to ignore. This piece explai...
Only Healthcare Stock Never: Why JNJ Deserves a Place in Your Portfolio
In a world of hot bets and fast trades, one blue-chip name stands out as a potential core holding. Learn why Johnson ...
What’s Wrong with UnitedHealth Stock? A Real-World Analysis
UnitedHealth stock has lagged in 2026, raising questions about its earnings, growth, and risks. This deep-dive breaks...
Related Topics
#Investing (42)
#Stock Market (11)
#Stock Analysis (11)
#Portfolio Management (5)
#Portfolio Strategy (5)
#Earnings (5)
#Dividend Investing (4)
#Novo Nordisk (4)
#Earnings Analysis (4)
#Income Investing (3)
#Biotech Investing (3)
#UnitedHealth (3)
#Pfizer (3)
#AI in Healthcare (2)
#Long-Term Investing (2)